ATN
Dead / Abandoned — Abandoned — failure to respond (as of 14 Feb 2023)
What this means for you
This application is over — abandoned 03 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97227543
- Mark type
- Stylized text
- Filed
- 19 Jan 2022
- Abandoned
- 03 Feb 2023
- Attorney of record
- Lawrence M. Green
Goods and services
- Class 005 — Pharmaceuticals: Research and development of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, cerebral venous sinus thrombosis, retinal disease and other disease arising from neuronal damage; and testing, inspection, research or development of pharmaceutical preparations for gene therapy or small molecule treatment
Owner
- NeuExcell Therapeutics Inc., Philadelphia, PA, US
Prosecution history
- 14 Feb 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 14 Feb 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 14 Feb 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 02 Aug 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Aug 2022 — NON-FINAL ACTION E-MAILED
- 02 Aug 2022 — NON-FINAL ACTION WRITTEN
- 01 Aug 2022 — ASSIGNED TO EXAMINER
- 25 Jan 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Jan 2022 — NEW APPLICATION ENTERED